| Income Statement for Vertex Pharmaceuticals Inc. (VRTX) | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Operating Revenue | 199,012 | 216,356 | 128,061 | 85,395 | 60,139 | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | 13,555 | 13,698 | 17,191 | 23,991 | 20,312 | | Gross Operating Profit | 212,567 | 230,054 | 145,252 | 109,386 | 80,451 | | | Selling/General/Admin Expense | (84,727) | (57,860) | (43,990) | (42,139) | (39,082) | | Research & Development | (513,054) | (371,713) | (248,540) | (192,162) | (199,636) | | EBITDA | (385,214) | (199,519) | (147,278) | (124,915) | (158,267) | | Depreciation & Amortization | (27,459) | (25,868) | (27,289) | (29,640) | (23,438) | | EBIT | (412,673) | (225,387) | (174,567) | (154,555) | (181,705) | | Interest Income | 30,798 | 23,024 | 11,994 | 10,323 | 15,412 | | Other Income, Net | - | 11,183 | 32,829 | 17,322 | 9,002 | | Total Income Avail For Interest Expense | (388,994) | (199,982) | (186,091) | (147,930) | (249,115) | | Interest Expense | (2,285) | (7,955) | (17,326) | (18,317) | (17,298) | | Pre-Tax Income | (391,279) | (207,937) | (203,417) | (166,247) | (266,413) | | Income Taxes | - | - | - | - | - | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | (391,279) | (207,937) | (203,417) | (166,247) | (266,413) | | Net Income from Discontinued Operations | - | - | - | - | 69,646 | | Net Income from Total Operations | (391,279) | (207,937) | (203,417) | (166,247) | (196,767) | | | Normalized Income | (384,160) | (199,135) | (147,070) | (145,227) | (174,589) | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | (7,119) | (8,802) | (56,347) | (21,020) | (91,824) | | Income from Cum. Effect of Acct Change | - | 1,046 | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | - | - | | Total Net Income | (391,279) | (206,891) | (203,417) | (166,247) | (196,767) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | - | | | Basic EPS from Continuing Operations | -3.03 | -1.84 | -2.28 | -2.12 | -3.46 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.90 | | Basic EPS from Total Operations | -3.03 | -1.84 | -2.28 | -2.12 | -2.56 | | | Diluted EPS from Continuing Operations | -3.03 | -1.84 | -2.28 | -2.12 | -3.46 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.90 | | Diluted EPS from Total Operations | -3.03 | -1.84 | -2.28 | -2.12 | -2.56 | | | |
